Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia	Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Recurrence, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 2	2025-08-08		NCT04684147

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Juventas Cell Therapy Ltd.	16

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Boren Hospital	Beijing	China	1
Henan Cancer Hospital	Zhengzhou	China	76
Institute of Hematology & Blood Diseases Hospital	Tianjin	China	24
Nanfang Hospital	Guangzhou	China	16
The Affiliated Hospital of Xuzhou Medical University	Xuzhou	China	16
The First Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	China	39
Tongji Hospital of Tongji University	Shanghai	China	1
Union Hospital Tongji Medical College Huazhong University Of Science And Technology	Wuhan	China	18
West China Hospital，Sichuan University	Chengdu	China	1
Xinqiao Hospital of TMMU	Chongqing	China	1
Yanda hospital, Hebei medical university	Sanhe	China	1